The
information contained in this release was correct as at
30 November
2024. Information on
the Company’s up to date net asset values can be found on the
London Stock Exchange website at:
https://www.londonstockexchange.com/exchange/news/market-news/market-news-home.html.
BLACKROCK
GREATER EUROPE INVESTMENT TRUST
PLC (LEI - 5493003R8FJ6I76ZUW55)
All
information is at
30 November
2024 and
unaudited.
Performance
at month end with net income reinvested
|
One
Month
|
Three
Months
|
One
Year
|
Three
Years
|
Launch
(20
Sep 04)
|
|
|
|
|
|
|
Net
asset value (undiluted)
|
-0.1%
|
-7.4%
|
6.3%
|
-9.3%
|
731.6%
|
Share
price
|
0.2%
|
-7.9%
|
5.7%
|
-18.1%
|
680.2%
|
FTSE
World Europe ex UK
|
-1.3%
|
-4.6%
|
8.2%
|
15.9%
|
435.1%
|
Sources:
BlackRock and Datastream
At month
end
Net
asset value (capital only):
|
591.68p
|
Net
asset value (including income):
|
591.80p
|
Share
price:
|
548.00p
|
Discount to NAV
(including income):
|
7.4%
|
Net
gearing:
|
10.4%
|
Net
yield1:
|
1.3%
|
Total
assets (including income):
|
£580.0m
|
Ordinary shares
in issue2:
|
98,013,150
|
Ongoing
charges3:
|
0.95%
|
1Based on an
interim dividend of 1.75p per share and final dividend of 5.25p per
share for the year ended 31 August
2024.
2Excluding
19,915,788 shares held in treasury.
3The Company’s
ongoing charges are calculated as a percentage of average daily net
assets and using the management fee and all other operating
expenses excluding finance costs, direct transaction costs, custody
transaction charges, VAT recovered, taxation, write back of prior
year expenses and certain non-recurring items for the year ended
31 August 2024.
Sector
Analysis
|
Total
Assets (%)
|
Industrials
|
30.5
|
Consumer
Discretionary
|
20.6
|
Health
Care
|
15.3
|
Technology
|
14.9
|
Financials
|
10.4
|
Basic
Materials
|
7.3
|
Real
Estate
|
1.3
|
Consumer
Staples
|
0.9
|
Net
Current Liabilities
|
-1.2
|
|
-----
|
|
100.0
|
|
=====
|
|
|
Country
Analysis
|
Total
Assets (%)
|
Netherlands
|
19.7
|
France
|
18.9
|
Switzerland
|
17.0
|
Denmark
|
10.3
|
United
Kingdom
|
7.4
|
Ireland
|
6.1
|
Sweden
|
4.9
|
Italy
|
4.4
|
Germany
|
4.1
|
United
States
|
4.1
|
Finland
|
2.3
|
Belgium
|
2.0
|
Net
Current Liabilities
|
-1.2
|
|
-----
|
|
100.0
|
|
=====
|
|
Top 10 holdings
|
Country
|
Fund %
|
Novo
Nordisk
|
Denmark
|
8.0
|
RELX
|
United
Kingdom
|
7.3
|
ASML
|
Netherlands
|
5.8
|
Schneider
Electric
|
France
|
5.3
|
Safran
|
France
|
4.7
|
Partners
Group
|
Switzerland
|
4.6
|
Ferrari
|
Italy
|
4.3
|
Hermès
|
France
|
4.1
|
Linde
|
United
States
|
4.1
|
Allied Irish
Banks (AIB)
|
Ireland
|
3.7
|
|
Commenting
on the markets, Stefan Gries and
Alexandra Dangoor, representing the
Investment Manager noted:
During the month,
the Company’s NAV was flat at -0.1% and the share price returned
0.2%. For reference, the FTSE World Europe ex UK Index returned
-1.3% during the period.1
Europe ex UK equities were down in November.
The disparity in performance between European and US equities
became more prominent during the month following the result of the
US election. Comparatively stronger US macroeconomic data and
investor confidence, bolstered by expectations of deregulation and
fiscal stimulus, drove US markets. On the other hand, Europe faced slightly worsening economic
conditions, highlighted by declining PMIs (the Purchasing Managers’
Index) and negative economic surprises, likely exacerbated by
uncertainty from US tariffs and the political backdrop in
France. One area which shows
continued progress in Europe is
inflation, supporting continued interest rate cuts into
2025.
European markets
were driven by expectations of what President-elect Donald Trump is likely to implement when he
comes into office. Over the period we also had the remainder of the
Q3 earnings. In summary, corporate reporting highlighted ongoing
trends: weakness in the automotive sector, polarization in the
luxury market, industrial short-cycle businesses awaiting a demand
rebound and strong performance from long-duration, capex focused
companies.
Going
into next year, we maintain a cautiously optimistic outlook on
European equities, given the combination of very low sentiment,
attractive valuations and the prospect of faster monetary easing in
Europe compared to the US. As
interest rates come down there are cyclical sectors such as
construction and other short-cycle industries that have faced
significant challenges which could see a recovery from depressed
levels.
Within the
reference index, sectors such as technology performed strongly
thanks to post-election optimism and strong investor sentiment.
Telecoms also rose, while sectors including materials and the
consumer sectors fell.
The
Company was ahead of its reference index during the month, largely
driven by stock selection whilst sector allocation was also
positive.
In
sector terms, the portfolio benefited from an overweight exposure
to industrials, particularly those with high exposure to the US,
with Trump's clear pro-business mandate being seen as beneficial
for growth and capex spend. Similarly, the portfolio’s higher
allocation to technology was positive as ‘animal spirits’ kicked
driving many cyclical shares higher.
On
the flip side, a lower weight to financials detracted, although
significantly offset by stock selection. Higher weights to consumer
discretionary and materials detracted from active
returns.
From
a stock specific perspective, there were a number of positive
contributors driven by the factors mentioned above. For example,
information and analytics company RELX was also amongst the best
performers, with approximately 55% of its revenue coming from
North America and the company's
operations in the US span across its various business segments,
including scientific, technical, and medical information, risk and
business analytics, legal, and exhibitions.
Linde
also benefited from strong exposure to the US. At Q3 results,
Americas represented about 43% of sales but 72% of the project
backlog, indicating strong opportunities for further growth in the
market.
Aerospace company
Safran was also amongst the top performers over the month,
benefiting from strong results in the previous month where trends
in the market continue to be favourable.
Within
financials, the portfolio benefited from its exposure to Partners
Group, an alternative asset manager. Shares performed strongly
during the month as financing conditions and deal activity
continues to improve. There is also increasing optimism around
potential deregulation and tax cuts in the US, which could create a
favourable environment for private equity investments.
In
the technology sector, BE Semi provided the top positive
attribution effect as shares bounced off recent weakness that had
been driven by the broader semiconductor sector sell-off. Whilst
traditional packaging markets have yet to recover, there is
optimism that we are at the bottom of the cycle, while their more
advanced Hybrid Bonding technology is also seeing encouraging order
trends.
Shares in
Chemometec continued on a positive trajectory over the month. The
company released encouraging results for the July-September quarter
and upgraded its full-year 2024/25 revenue and EBITDA guidance. We
remain encouraged by the company’s accelerating top line momentum
driven by new launches.
On
the negative side, a holding in Kingspan was the largest detractor
following a trading update that guided to flat year-on-year EBIT, a
small cut to expectation. Whilst price-cost has been a headwind for
Kingspan in 2024, the results demonstrated improving volume
dynamics and also solid order intake which should be bode well for
2025.
Finally, shares
in Ferrari detracted in the month, having performed well for much
of the year. The company reported overall solid results but there
was a lack of upgrades which led to some profit taking. Management
expressed their increased confidence in earnings over the medium
term supported by a full order book.
Outlook
We
believe underlying economic conditions remain robust with consumers
and corporates in healthy positions. Inflation is retreating and
rate cutting cycles have begun in earnest across the globe, which
increases investor propensity to move up the risk curve in search
for higher returns. We continue to take scaled and deliberate
cyclical risk in European equities as profitability continues to be
resilient in many European cyclicals, with their sensitivity to
economic shocks and the domestic economy significantly reduced.
After a long period of underinvestment, long duration and
structural investment spend is now in place to support these
businesses and their underlying earnings should move higher over a
multi-year period.
Alongside
investment opportunities afforded by structural forces, such as the
energy transition or AI, we also detect a cyclical upturn in a
variety of industries like construction, life-sciences and
chemicals which have suffered from pronounced volume declines for
the best part of two years. We remain positive on the outlook,
given a structurally improved market composition in Europe, potential for a cyclical recovery, and
valuations in the European market at a record wide discount
relative to the US.
1Source:
BlackRock
16 December 2024
ENDS
Latest
information is available by typing www.blackrock.com/uk/brge
on
the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800"
on Topic 3 (ICV terminal).
Neither the
contents of the Manager’s website nor the contents of any website
accessible from hyperlinks on the Manager’s website (or any other
website) is incorporated into, or forms part of, this
announcement.